Snowflake Inc. (SNOW) director sells 400,000 shares under 10b5-1 plan
Rhea-AI Filing Summary
Snowflake director Frank Slootman exercised a fully vested stock option for 400,000 shares of Common Stock at an exercise price of $8.880 per share on May 28, 2026, then sold 400,000 common shares in multiple transactions at weighted-average prices between $229.670 and $238.000, effected pursuant to a 10b5-1 trading plan adopted on September 19, 2025. After these transactions, he holds 38,046 Snowflake shares directly and 207,855 shares indirectly through family trusts.
Positive
- None.
Negative
- None.
Insights
Pre-planned option exercise and matched share sale, with sizable equity stake remaining.
Frank Slootman exercised 400,000 stock options at an exercise price of $8.88 and sold an equal 400,000 shares of Snowflake common stock on May 28, 2026. Prices were reported as weighted averages, with trades executed in ranges roughly from $229.67 to $238.00.
The filing notes these transactions were effected under a Rule 10b5-1 trading plan adopted on September 19, 2025, suggesting a pre-arranged liquidity program rather than ad hoc market timing. After the exercise and sales, Slootman directly owns 438,046 shares and holds 5,936,655 stock options plus additional shares via family trusts, indicating a substantial continuing exposure to Snowflake’s equity.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 400,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 400,000 | $8.88 | $3.55M |
| Sale | Common Stock | 28,740 | $230.174 | $6.62M |
| Sale | Common Stock | 13,976 | $231.063 | $3.23M |
| Sale | Common Stock | 41,321 | $232.307 | $9.60M |
| Sale | Common Stock | 124,883 | $233.17 | $29.12M |
| Sale | Common Stock | 143,283 | $234.089 | $33.54M |
| Sale | Common Stock | 29,148 | $234.961 | $6.85M |
| Sale | Common Stock | 14,463 | $236.535 | $3.42M |
| Sale | Common Stock | 4,186 | $237.289 | $993K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (14)
- F1. The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
- F2. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $229.670 to $230.660, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $230.680 to $231.670, inclusive.
- F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $231.700 to $232.685, inclusive.
- F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $232.700 to $233.690, inclusive.
- F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $233.700 to $234.685, inclusive.
- F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $234.720 to $235.560, inclusive.
- F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $236.020 to $237.000, inclusive.
- F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $237.050 to $238.000, inclusive.
- F10. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
- F11. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
- F12. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
- F13. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
- F14. The stock option is fully vested.
Key Figures
Key Terms
10b5-1 trading plan regulatory
weighted-average price financial
Grantor Retained Annuity Trust financial
AI-generated analysis. How Rhea-AI works. Not financial advice.